Donoghue
Bryan J. Donoghue, St. Albans GB
Patent application number | Description | Published |
---|---|---|
20120314564 | CASCADE SYSTEM FOR NETWORK UNITS - In one embodiment, a method is described for detecting an operational failure between the network unit and an adjacent network unit in the stack; controlling the switching engine to redirect packets which would otherwise be sent from a particular port to the adjacent network unit to be forwarded from another port to be sent to a different network unit in the stack; and entering the switching engine into a bypass mode in response to control data indicating an operational failure between at least two other network units in the stack to cause packets to be forwarded without being re-directed by the switching engine. | 12-13-2012 |
Bryan James Donoghue, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100128817 | WIRELESS RECEIVER AND METHOD OF SAVING POWER - A receiver ( | 05-27-2010 |
Gavin Donoghue, West Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20120270935 | FORMULATIONS - An antimicrobial and/or anti-acne formulation containing either usnic acid or an usnate, together with (a) a primary solvent or solvent system in which the usnic acid or usnate is at least partially dissolved; (b) a glycol; and (c) a hydrophobic fatty acid, fatty alcohol or derivative thereof. The formulation may also contain (d) an alkylene glycol derivative. | 10-25-2012 |
Gavin Donoghue, Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20140057976 | USNIC ACID TOPICAL FORMULATION - Topical skin treatment formulation containing usnic acid or an usnate salt, dissolved in a solvent system comprising (i) dimethyl isosorbide; (ii) a C1 to C9 alkyl salicylate; and (iii) a glyceryl fatty acid ester. The solvent system may also comprise an alcohol, a polyoxyalkylene-based solvent, and/or a C1 to C4 alkyl glucose ester. The formulation may be used in the treatment of microbial conditions, in particular acne. The solvent system assists in the effective dissolution of the usnic acid or usnate and in targeting its delivery to relevant sites on the skin. | 02-27-2014 |
20140107081 | SALICYLIC ACID TOPICAL FORMULATION - Topical skin treatment formulation containing salicylic acid or a derivative thereof, dissolved in a solvent system comprising (i) dimethyl isosorbide; (ii) a C1 to C9 alkyl salicylate; and (iii) a glyceryl fatty acid ester. The solvent system may also comprise an alcohol, a polyoxyalkylene-based solvent, and/or a C1 to C4 alkyl glucose ester. The formulation may be used in the treatment of acne. The solvent system improves the targeted delivery of the salicylic acid or derivative to relevant sites on the skin. | 04-17-2014 |
Tony John Donoghue, Crowthorne GB
Patent application number | Description | Published |
---|---|---|
20090203973 | Conveying Real Time Medical Data - There is provided apparatus for conveying real-time medical data received from patient connected terminals within a hospital to clinician. The apparatus is characterised in that the clinicians receive data from the apparatus via mobile devices ( | 08-13-2009 |
20090259729 | Secure Transfer of Data Files - The secure transfer of data files between secure environments ( | 10-15-2009 |